Show simple item record

dc.contributor.authorAuthorBernal-Ramirez, Judith
dc.contributor.authorAuthorDíaz-Vesga, Magda C.
dc.contributor.authorAuthorTalamilla, Matias
dc.contributor.authorAuthorMéndez, Andrea
dc.contributor.authorAuthorQuiroga, Clara
dc.contributor.authorAuthorGarza-Cervantes, Javier A.
dc.contributor.authorAuthorLázaro-Alfaro, Anay
dc.contributor.authorAuthorJerjes-Sanchez, Carlos
dc.contributor.authorAuthorHenríquez, Mauricio
dc.contributor.authorAuthorGarcía-Rivas, Gerardo
dc.contributor.authorAuthorPedrozo, Zully
dc.contributor.otherCareerFacultad de salud, ciencias sociales y deporteses
dc.date.accessionedDate Accessioned2022-05-27T17:18:29Z
dc.date.availableDate Available2022-05-27T17:18:29Z
dc.date.issuedDate Issued2021-08-28
dc.identifier.citationReferencia BibliográficaOxidative Medicine and Cellular Longevity, 21 p.
dc.identifier.issnISSN1942-0900
dc.identifier.uriURIhttp://repositorio.udla.cl/xmlui/handle/udla/1101
dc.identifier.uriURIhttps://www.hindawi.com/journals/omcl/
dc.description.abstractAbstractThe right and left ventricles have traditionally been studied as individual entities. Furthermore, modifications found in diseased left ventricles are assumed to influence on right ventricle alterations, but the connection is poorly understood. In this review, we describe the differences between ventricles under physiological and pathological conditions. Understanding the mechanisms that differentiate both ventricles would facilitate a more effective use of therapeutics and broaden our knowledge of right ventricle (RV) dysfunction. RV failure is the strongest predictor of mortality in pulmonary arterial hypertension, but at present, there are no definitive therapies directly targeting RV failure. We further explore the current state of drugs and molecules that improve RV failure in experimental therapeutics and clinical trials to treat pulmonary arterial hypertension and provide evidence of their potential benefits in heart failure.es
dc.format.extentdc.format.extent21 páginas
dc.format.extentdc.format.extent982.3Kb
dc.format.mimetypedc.format.mimetypePDF
dc.language.isoLanguage ISOenes
dc.publisherPublisherHindawi Limited
dc.sourceSourcesOxidative Medicine and Cellular Longevity
dc.subjectSubjectPulmonary arterial-hypertension
dc.subjectSubjectMonocrotaline-induced pulmonary
dc.subjectSubjectCardiac-hypertrophy
dc.subject.lcshdc.subject.lcshRenin-angiotensin system
dc.subject.lcshdc.subject.lcshHeart-failure
dc.subject.lcshdc.subject.lcshRho-associated protein kinases
dc.subject.lcshdc.subject.lcshSarcoplasmic-reticulum
dc.titleTitleExploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunctiones
dc.typeDocument TypeArtículoes
dc.udla.catalogadordc.udla.catalogadorCBM
dc.udla.indexdc.udla.indexSCOPUS
dc.identifier.doidc.identifier.doihttps://doi.org/10.1155%2F2021%2F9993060
dc.udla.privacidaddc.udla.privacidadDocumento públicoes


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record